Page last updated: 2024-08-21

c.i. 42510 and Alcoholic Fatty Liver

c.i. 42510 has been researched along with Alcoholic Fatty Liver in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ci, LL; Liu, ZN; Lv, XW; Su, QQ; Tian, YY	1

Other Studies

1 other study(ies) available for c.i. 42510 and Alcoholic Fatty Liver

Article	Year
Purinergic P2X7 receptor blockade mitigates alcohol-induced steatohepatitis and intestinal injury by regulating MEK1/2-ERK1/2 signaling and egr-1 activity. International immunopharmacology, 2019, Volume: 66 Topics: Animals; Cytokines; Disease Models, Animal; Early Growth Response Protein 1; Fatty Liver, Alcoholic; Gastrointestinal Microbiome; Humans; Inflammation; Intestines; Male; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Purinergic P2Y Receptor Antagonists; Pyridines; Rosaniline Dyes; Signal Transduction; Tetrazoles	2019

Article

Year

Purinergic P2X7 receptor blockade mitigates alcohol-induced steatohepatitis and intestinal injury by regulating MEK1/2-ERK1/2 signaling and egr-1 activity.

International immunopharmacology, 2019, Volume: 66

Topics: Animals; Cytokines; Disease Models, Animal; Early Growth Response Protein 1; Fatty Liver, Alcoholic; Gastrointestinal Microbiome; Humans; Inflammation; Intestines; Male; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Purinergic P2Y Receptor Antagonists; Pyridines; Rosaniline Dyes; Signal Transduction; Tetrazoles

2019